Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1987 Jan;146(1):46–51.

Visual Hallucinations

Clinical Occurrence and Use in Differential Diagnosis

Jeffrey L Cummings 1,2,3, Bruce L Miller 1,2,3
PMCID: PMC1307180  PMID: 3825109

Abstract

Visual hallucinations occur in diverse clinical circumstances including ophthalmologic diseases, neurologic disorders, toxic and metabolic disorders and idiopathic psychiatric illnesses. Their content, duration and timing relate to their cause and provide useful differential diagnostic information. Hallucinations must be distinguished from delusions and confabulation. A systematic approach to differentiating among hallucinatory syndromes may improve diagnostic accuracy.

Full text

PDF
49

Images in this article

48Figure 2.
on p.48

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTLET J. E. A. A case of organized visual hallucinations in an old man with cataract, and their relation to the phenomena of the phantom limb. Brain. 1951 Sep;74(3):363–373. doi: 10.1093/brain/74.3.363. [DOI] [PubMed] [Google Scholar]
  2. Barnes F. F. Precipitation of mania and visual hallucinations by Amoxapine Hydrochloride. Compr Psychiatry. 1982 Nov-Dec;23(6):590–592. doi: 10.1016/0010-440x(82)90052-9. [DOI] [PubMed] [Google Scholar]
  3. Bender M. B., Feldman M., Sobin A. J. Palinopsia. Brain. 1968 Jun;91(2):321–338. doi: 10.1093/brain/91.2.321. [DOI] [PubMed] [Google Scholar]
  4. Berrios G. E., Brook P. The Charles Bonnet syndrome and the problem of visual perceptual disorders in the elderly. Age Ageing. 1982 Feb;11(1):17–23. doi: 10.1093/ageing/11.1.17. [DOI] [PubMed] [Google Scholar]
  5. Brawley P., Duffield J. C. The pharmacology of hallucinogens. Pharmacol Rev. 1972 Mar;24(1):31–66. [PubMed] [Google Scholar]
  6. Brust J. C., Behrens M. M. "Release hallucinations" as the major symptom of posterior cerebral artery occlusion: a report of 2 cases. Ann Neurol. 1977 Nov;2(5):432–436. doi: 10.1002/ana.410020516. [DOI] [PubMed] [Google Scholar]
  7. Channer K. S., Stanley S. Persistent visual hallucinations secondary to chronic solvent encephalopathy: case report and review of the literature. J Neurol Neurosurg Psychiatry. 1983 Jan;46(1):83–86. doi: 10.1136/jnnp.46.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cogan D. G. Visual hallucinations as release phenomena. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1973 Aug 23;188(2):139–150. doi: 10.1007/BF00407835. [DOI] [PubMed] [Google Scholar]
  9. Cohn R. Phantom vision. Arch Neurol. 1971 Nov;25(5):468–471. doi: 10.1001/archneur.1971.00490050102009. [DOI] [PubMed] [Google Scholar]
  10. Cummings J. L., Barritt C. F., Horan M. Delusions induced by procaine penicillin: case report and review of the syndrome. Int J Psychiatry Med. 1986;16(2):163–168. doi: 10.2190/knqt-ueu4-gaq2-57l6. [DOI] [PubMed] [Google Scholar]
  11. Cummings J. L., Syndulko K., Goldberg Z., Treiman D. M. Palinopsia reconsidered. Neurology. 1982 Apr;32(4):444–447. doi: 10.1212/wnl.32.4.444. [DOI] [PubMed] [Google Scholar]
  12. DEWHURST K., PEARSON J. Visual hallucinations of the self in organic disease. J Neurol Neurosurg Psychiatry. 1955 Feb;18(1):53–57. doi: 10.1136/jnnp.18.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Damas-Mora J., Skelton-Robinson M., Jenner F. A. The Charles Bonnet syndrome in perspective. Psychol Med. 1982 May;12(2):251–261. doi: 10.1017/s0033291700046584. [DOI] [PubMed] [Google Scholar]
  14. Davis F. A., Bergen D., Schauf C., McDonald I., Deutsch W. Movement phosphenes in optic neuritis: a new clinical sign. Neurology. 1976 Nov;26(11):1100–1104. doi: 10.1212/wnl.26.11.1100. [DOI] [PubMed] [Google Scholar]
  15. Endo M., Hirai K., Ohara M. Paranoid-hallucinatory state induced in a depressive patient by methyldopa: a case report. Psychoneuroendocrinology. 1978 Apr;3(2):211–215. doi: 10.1016/0306-4530(78)90010-0. [DOI] [PubMed] [Google Scholar]
  16. Filley C. M., Graff-Richard N. R., Lacy J. R., Heitner M. A., Earnest M. P. Neurologic manifestations of podophyllin toxicity. Neurology. 1982 Mar;32(3):308–311. doi: 10.1212/wnl.32.3.308. [DOI] [PubMed] [Google Scholar]
  17. Fitzgerald B. A., Wells C. E. Hallucinations as a conversion reaction. Dis Nerv Syst. 1977 May;38(5):381–383. [PubMed] [Google Scholar]
  18. Goetz C. G., Tanner C. M., Klawans H. L. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry. 1982 Apr;139(4):494–497. doi: 10.1176/ajp.139.4.494. [DOI] [PubMed] [Google Scholar]
  19. Golden R. N., James S. P., Sherer M. A., Rudorfer M. V., Sack D. A., Potter W. Z. Psychoses associated with bupropion treatment. Am J Psychiatry. 1985 Dec;142(12):1459–1462. doi: 10.1176/ajp.142.12.1459. [DOI] [PubMed] [Google Scholar]
  20. Goodwin D. W., Alderson P., Rosenthal R. Clinical significance of hallucinations in psychiatric disorders. A study of 116 hallucinatory patients. Arch Gen Psychiatry. 1971 Jan;24(1):76–80. doi: 10.1001/archpsyc.1971.01750070078011. [DOI] [PubMed] [Google Scholar]
  21. Greenberg R., Pearlman C. Delirium tremens and dreaming. Am J Psychiatry. 1967 Aug;124(2):133–142. doi: 10.1176/ajp.124.2.133. [DOI] [PubMed] [Google Scholar]
  22. Hachinski V. C., Porchawka J., Steele J. C. Visual symptoms in the migraine syndrome. Neurology. 1973 Jun;23(6):570–579. doi: 10.1212/wnl.23.6.570. [DOI] [PubMed] [Google Scholar]
  23. Hemmingsen R., Rafaelsen O. J. Hypnagogic and hypnopompic hallucinations during amitriptyline treatment. Acta Psychiatr Scand. 1980 Oct;62(4):364–368. doi: 10.1111/j.1600-0447.1980.tb00622.x. [DOI] [PubMed] [Google Scholar]
  24. Herridge C. F., a'Brook M. F. Ephedrine psychosis. Br Med J. 1968 Apr 20;2(5598):160–160. doi: 10.1136/bmj.2.5598.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jacobs L., Karpik A., Bozian D., Gøthgen S. Auditory-visual synesthesia: sound-induced photisms. Arch Neurol. 1981 Apr;38(4):211–216. doi: 10.1001/archneur.1981.00510040037005. [DOI] [PubMed] [Google Scholar]
  26. Jones R. F., Lance J. W. Bacloffen (Lioresal) in the long-term management of spasticity. Med J Aust. 1976 May 1;1(18):654–657. doi: 10.5694/j.1326-5377.1976.tb140942.x. [DOI] [PubMed] [Google Scholar]
  27. Kölmel H. W. Complex visual hallucinations in the hemianopic field. J Neurol Neurosurg Psychiatry. 1985 Jan;48(1):29–38. doi: 10.1136/jnnp.48.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. LEWIS D. J. Lilliputian hallucinations in the functional psychoses. Can Psychiatr Assoc J. 1961 Aug;6:177–201. doi: 10.1177/070674376100600402. [DOI] [PubMed] [Google Scholar]
  29. LHERMITTE J. Visual hallucination of the self. Br Med J. 1951 Mar 3;1(4704):431–434. doi: 10.1136/bmj.1.4704.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. LINN L., KAHN R. L., COLES R., COHEN J., MARSHALL D., WEINSTEIN E. A. Patterns of behavior disturbance following cataract extraction. Am J Psychiatry. 1953 Oct;110(4):281–289. doi: 10.1176/ajp.110.4.281. [DOI] [PubMed] [Google Scholar]
  31. Lance J. W. Simple formed hallucinations confined to the area of a specific visual field defect. Brain. 1976 Dec;99(4):719–734. doi: 10.1093/brain/99.4.719. [DOI] [PubMed] [Google Scholar]
  32. Lucas A. R., Weiss M. Methylphenidate hallucinosis. JAMA. 1971 Aug 23;217(8):1079–1081. [PubMed] [Google Scholar]
  33. MEDLICOTT R. W. An inquiry into the significance of hallucinations with special reference to their occurrence in the sane. Int Rec Med Gen Pract Clin. 1958 Nov;171(11):664–677. [PubMed] [Google Scholar]
  34. MOTT R. H., SMALL I. F., ANDERSON J. M. COMPARATIVE STUDY OF HALLUCINATIONS. Arch Gen Psychiatry. 1965 Jun;12:595–601. doi: 10.1001/archpsyc.1965.01720360067011. [DOI] [PubMed] [Google Scholar]
  35. MacDonald W. S., Oden C. W., Jr Aumakua: behavioral direction visions in Hawaiians. J Abnorm Psychol. 1977 Apr;86(2):189–194. doi: 10.1037//0021-843x.86.2.189. [DOI] [PubMed] [Google Scholar]
  36. Matchett W. F. Repeated hallucinatory experiences as a part of the mourning process among Hopi Indian women. Psychiatry. 1972 May;35(2):185–194. doi: 10.1080/00332747.1972.11023711. [DOI] [PubMed] [Google Scholar]
  37. Miller R. R. Clinical effects of pentazocine in hospitalized medical patients. J Clin Pharmacol. 1975 Feb-Mar;15(2-3):198–205. doi: 10.1002/j.1552-4604.1975.tb02357.x. [DOI] [PubMed] [Google Scholar]
  38. Mize K. Visual hallucinations following viral encephalitis: a self report. Neuropsychologia. 1980;18(2):193–202. doi: 10.1016/0028-3932(80)90065-2. [DOI] [PubMed] [Google Scholar]
  39. NEBEL B. R. The phosphene of quick eye motion. AMA Arch Ophthalmol. 1957 Aug;58(2):235–243. doi: 10.1001/archopht.1957.00940010247010. [DOI] [PubMed] [Google Scholar]
  40. Norman T. R., Judd F., Holwill B. J., Burrows G. D. Doxepin and visual hallucinations. Aust N Z J Psychiatry. 1982 Dec;16(4):295–296. doi: 10.3109/00048678209161271. [DOI] [PubMed] [Google Scholar]
  41. PRIESTLEY B. S., FOREE K. Clinical significance of some entoptic phenomena. AMA Arch Ophthalmol. 1955 Mar;53(3):390–397. doi: 10.1001/archopht.1955.00930010392010. [DOI] [PubMed] [Google Scholar]
  42. Petursson H. Diethylpropion and paranoid psychosis. Aust N Z J Psychiatry. 1979 Mar;13(1):67–68. doi: 10.3109/00048677909159112. [DOI] [PubMed] [Google Scholar]
  43. Price W., Coli L., Brandstetter R. D., Gotz V. P. Ranitidine-associated hallucinations. Eur J Clin Pharmacol. 1985;29(3):375–376. doi: 10.1007/BF00544097. [DOI] [PubMed] [Google Scholar]
  44. ROZANSKI J. Peduncular hallucinosis following vertebral angiography. Neurology. 1952 Jul-Aug;2(4):341–349. doi: 10.1212/wnl.2.7-8.341. [DOI] [PubMed] [Google Scholar]
  45. RUSSELL W. R., WHITTY C. W. Studies in traumatic epilepsy. 3. Visual fits. J Neurol Neurosurg Psychiatry. 1955 May;18(2):79–96. doi: 10.1136/jnnp.18.2.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sandyk R., Gillman M. A. Lithium-induced visual hallucinations: evidence for possible opioid mediation. Ann Neurol. 1985 Jun;17(6):619–620. doi: 10.1002/ana.410170620. [DOI] [PubMed] [Google Scholar]
  47. Sedman G. A comparative study of pseudohallucinations, imagery and true hallucinations. Br J Psychiatry. 1966 Jan;112(482):9–17. doi: 10.1192/bjp.112.482.9. [DOI] [PubMed] [Google Scholar]
  48. Shawn D. H., McGuigan M. A. Poisoning from dermal absorption of promethazine. Can Med Assoc J. 1984 Jun 1;130(11):1460–1461. [PMC free article] [PubMed] [Google Scholar]
  49. Sheehy L. M., Maxmen J. S. Phenelzine-induced psychosis. Am J Psychiatry. 1978 Nov;135(11):1422–1423. doi: 10.1176/ajp.135.11.1422. [DOI] [PubMed] [Google Scholar]
  50. Smith R. A., Gelles D. B., Vanderhaeghen J. J. Subcortical visual hallucinations. Cortex. 1971 Jun;7(2):162–168. doi: 10.1016/s0010-9452(71)80012-6. [DOI] [PubMed] [Google Scholar]
  51. Snow S. S., Logan T. P., Hollender M. H. Nasal spray 'addiction' and psychosis: a case report. Br J Psychiatry. 1980 Mar;136:297–299. doi: 10.1192/bjp.136.3.297. [DOI] [PubMed] [Google Scholar]
  52. TODD J. The syndrome of Alice in Wonderland. Can Med Assoc J. 1955 Nov 1;73(9):701–704. [PMC free article] [PubMed] [Google Scholar]
  53. WEINER M. F. [Hallucinations in children]. Arch Gen Psychiatry. 1961 Dec;5:544–553. doi: 10.1001/archpsyc.1961.01710180028004. [DOI] [PubMed] [Google Scholar]
  54. White M. C., Silverman J. J., Harbison J. W. Psychosis associated with clonazepam therapy for blepharospasm. J Nerv Ment Dis. 1982 Feb;170(2):117–119. doi: 10.1097/00005053-198202000-00010. [DOI] [PubMed] [Google Scholar]
  55. White N. J. Complex visual hallucinations in partial blindness due to eye disease. Br J Psychiatry. 1980 Mar;136:284–286. doi: 10.1192/bjp.136.3.284. [DOI] [PubMed] [Google Scholar]
  56. Yates D. Syncope and visual hallucinations, apparently from timolol. JAMA. 1980 Aug 22;244(8):768–769. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES